Subcutaneous immunoglobulin replacement for treatment of humoral immune dysfunction in patients with chronic lymphocytic leukemia

• S. Shahzad Mustafa ,

  Roles Conceptualization, Investigation, Writing – original draft

  * E-mail: shahzad.mustafa@rochesterregional.org

  Affiliations Division of Allergy, Immunology, Rheumatology, Rochester Regional Health, Rochester, New York, United States of America, Division of Allergy, Immunology, Rheumatology, University of Rochester School of Medicine & Dentistry, Rochester, New York, United States of America

  https://orcid.org/0000-0001-9691-7590

  ⨯
• Saad Jamshed,

  Roles Conceptualization, Writing – review & editing

  Affiliation Division of Hematology and Oncology, Rochester Regional Health, Rochester, New York, United States of America

  ⨯
• Karthik Vadamalai,

  Roles Data curation, Formal analysis

  Affiliation Division of Critical Care, Mercy Hospital, Springfield, Missouri, United States of America

  ⨯
• Allison Ramsey

  Roles Conceptualization, Writing – review & editing

  Affiliations Division of Allergy, Immunology, Rheumatology, Rochester Regional Health, Rochester, New York, United States of America, Division of Allergy, Immunology, Rheumatology, University of Rochester School of Medicine & Dentistry, Rochester, New York, United States of America

  ⨯